Pharmaceutical attention in the treatment of obesity involving analogues of Glucagon-like peptide 1 (GPL-1). RSD [Internet]. 2022 May 29 [cited 2025 Dec. 5];11(7):e41011730134. Available from: https://rsdjournal.org/rsd/article/view/30134